I like to inform and educate my patients to include them in the decision process and intervene only when necessary. I will be facile and choose what’s best for the patient according to the circumstances while listening for the answer — it’s usually in the complaint — and being compassionate. Dr. Kaynan is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Hydronephrosis, Reconstructive Urology Surgery, and Ureteroscopy.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.

Eric Whitman is a General Surgeon and a Surgical Oncologist in Morristown, New Jersey. Dr. Whitman is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Melanoma, Pancreatic Cancer, Hyperparathyroidism, and Familial Pancreatic Cancer.

The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostate Cancer, Prostatectomy, and Nephrectomy.

Gregg Zimmerman is a Urologist in Denville, New Jersey. Dr. Zimmerman is rated as a Distinguished provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Congenital Mesoblastic Nephroma, Enlarged Prostate (BPH), Perirenal Abscess, Vasectomy, and Reconstructive Urology Surgery. Dr. Zimmerman is currently accepting new patients.

I feel privileged to have completed my residency at Beth Israel Medical Center in New York City, which was the first center in Manhattan to perform the da Vinci robotic prostatectomy. As such, robotic laparoscopic surgery has been part of my urologic experience since the first day of my training. This fact, along with advanced training in endoscopic management of kidney stones combines to create a minimally invasive approach to all urologic conditions. I strive to make patients feel comfortable in the office so that they are then at ease when undergoing tests or surgical procedures. Dr. Berman is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Prostate Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Anisha Rodrigues is a primary care provider, practicing in Internal Medicine in Florham Park, New Jersey. Dr. Rodrigues is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and Hypothyroidism. Dr. Rodrigues is currently accepting new patients.

Ashish Chandwani is an Infectious Disease provider in Florham Park, New Jersey. Dr. Chandwani is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Pneumonia, COVID-19, Strep Throat, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Chandwani is currently accepting new patients.

Renee Frankel is an Infectious Disease provider in Florham Park, New Jersey. Dr. Frankel is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Pneumonia, Strep Throat, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Frankel is currently accepting new patients.

Kjell Youngren is a Urologist in Morristown, New Jersey. Dr. Youngren is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Boils, and Ureteroscopy. Dr. Youngren is currently accepting new patients.

Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

Thaddeus Yablonsky is a Radiologist and an Interventional Radiologist in Morristown, New Jersey. Dr. Yablonsky is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Diverticular Disease, Bile Duct Obstruction, Chylous Ascites, Liver Embolization, and Gastrostomy. Dr. Yablonsky is currently accepting new patients.

Benjamin Freeman is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Freeman is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Familial Colorectal Cancer, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Freeman is currently accepting new patients.

Fazal Bari is a Hematologist and an Oncologist in Mountain Lakes, New Jersey. Dr. Bari is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Colorectal Cancer. Dr. Bari is currently accepting new patients.

Dr. Pressler always strives to provide compassionate and personalized care for all of his patients. He is a recognized regional expert in urologic oncology and robotic surgery. Dr. Pressler has the most experience using the da Vinci robot in northwest NJ. Dr. Pressler specializes in robotic prostatectomy, cystectomy, partial, nephrectomy and urinary tract reconstruction. He is the only urologist in NJ to perform neobladder reconstruction entirely robotic/laparoscopically. Dr. Pressler is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Hydronephrosis, Obstructive Uropathy, Prostate Cancer, Ureteroscopy, and Bladder Reconstruction.

It’s important to me to connect with my patients on a personal level, which helps me better understand their problems and concerns. I’m genuinely interested in them and their families and improving their quality of life, and I encourage everyone in the practice to treat patients with that same level of compassion. My patients perceive me as an experienced, compassionate urologic surgeon they can rely on. I enjoy treating the entire range of urologic disorders, with a special interest in oncology and kidney problems. Dr. Taylor is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

I have been blessed to have received some of the finest urologic training available in the United States. My teachers and mentors at Cornell and Harvard have influenced me to simply be the best physician, surgeon, and person that I can be. I love my profession and cherish the opportunity to help the people of my community every day that I am in the office, hospital or operating room. I strive to treat every patient I see as if they were a family member and feel that a compassionate and individualized approach to health care is paramount in achieving the finest outcomes for my patients.Dr. Sutaria is one of the region’s top Robotic and minimally invasive surgeons and has trained other surgeons in the use of the Robotic Technology. Dr. Sutaria is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Obstructive Uropathy, Kidney Stones, Boils, Ureteroscopy, and Bladder Reconstruction.

My goal is to make lasting improvements in my patients’ lives and be the go-to guy who is respected for solving the most complex urologic problems. This way, patients and doctors can turn to me knowing I can tackle their urologic needs no matter how big or small. I chose urology because it involves a wide array of surgical problems while allowing me to maintain long-term relationships with patients. I get great satisfaction helping my patients understand their problems. It is important to be able to discuss and offer all treatment options available, both surgical and nonsurgical. If surgery is necessary, I offer the latest, least invasive techniques to return you to your normal life more quickly. Dr. Steinberg is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Hydronephrosis, Ureteroscopy, and Reconstructive Urology Surgery.